Ameritas Investment Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.9K | Buy |
25,525
+5,145
| +25% | +$18.7K | ﹤0.01% | 1808 |
|
|
2025
Q1 | $39.1K | Hold |
20,380
| – | – | ﹤0.01% | 2247 |
|
|
2024
Q4 | $38.7K | Hold |
20,380
| – | – | ﹤0.01% | 2338 |
|
|
2024
Q3 | $26.9K | Hold |
20,380
| – | – | ﹤0.01% | 2506 |
|
|
2024
Q2 | $20.8K | Buy |
+20,380
| New | +$20.8K | ﹤0.01% | 2590 |
|
|
2022
Q2 | – | Sell |
-11,500
| Closed | -$8K | – | 3059 |
|
|
2022
Q1 | $8K | Hold |
11,500
| – | – | ﹤0.01% | 2849 |
|
|
2021
Q4 | $26K | Hold |
11,500
| – | – | ﹤0.01% | 2515 |
|
|
2021
Q3 | $33K | Hold |
11,500
| – | – | ﹤0.01% | 2405 |
|
|
2021
Q2 | $44K | Hold |
11,500
| – | – | ﹤0.01% | 2263 |
|
|
2021
Q1 | $39K | Hold |
11,500
| – | – | ﹤0.01% | 2221 |
|
|
2020
Q4 | $32K | Hold |
11,500
| – | – | ﹤0.01% | 2230 |
|
|
2020
Q3 | $29K | Hold |
11,500
| – | – | ﹤0.01% | 2176 |
|
|
2020
Q2 | $156K | Buy |
11,500
+1,352
| +13% | +$18.3K | 0.01% | 1131 |
|
|
2020
Q1 | $77K | Hold |
10,148
| – | – | ﹤0.01% | 1414 |
|
|
2019
Q4 | $64K | Hold |
10,148
| – | – | ﹤0.01% | 1764 |
|
|
2019
Q3 | $40K | Hold |
10,148
| – | – | ﹤0.01% | 2007 |
|
|
2019
Q2 | $49K | Buy |
10,148
+3,480
| +52% | +$16.8K | ﹤0.01% | 1918 |
|
|
2019
Q1 | $55K | Hold |
6,668
| – | – | ﹤0.01% | 1838 |
|
|
2018
Q4 | $37K | Buy |
6,668
+2,855
| +75% | +$15.8K | ﹤0.01% | 1976 |
|
|
2018
Q3 | $34K | Hold |
3,813
| – | – | ﹤0.01% | 2197 |
|
|
2018
Q2 | $38K | Hold |
3,813
| – | – | ﹤0.01% | 2157 |
|
|
2018
Q1 | $36K | Hold |
3,813
| – | – | ﹤0.01% | 2091 |
|
|
2017
Q4 | $57K | Buy |
3,813
+1,013
| +36% | +$15.1K | ﹤0.01% | 1851 |
|
|
2017
Q3 | $46K | Hold |
2,800
| – | – | ﹤0.01% | 1945 |
|
|
2017
Q2 | $40K | Hold |
2,800
| – | – | ﹤0.01% | 2047 |
|
|
2017
Q1 | $26K | Buy |
+2,800
| New | +$26K | ﹤0.01% | 2249 |
|